Ramosetron Hydrochloride Sustained-release Patches(Hangzhou Paqis Pharma)

盐酸雷莫司琼缓释贴片（杭州帕琦斯医药）

Report date: 2025/07/28 16:02:07

Base Information

Drug NameRamosetron Hydrochloride Sustained-release Patches(Hangzhou Paqis Pharma)
Drug Alias Nameramosetronum雷莫司琼ramosetron盐酸雷莫司琼缓释贴片（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingPostoperative Nausea and Vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Paqis Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Paqis Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomitingPostoperative Nausea and Vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG